Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2026-04-22 Governance Information
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
公司章程（2026年4月修订）
Governance Information Classification · 90% confidence The document contains the full text of the company’s Articles of Association (公司章程), detailing internal rules on corporate governance, board structure, shareholder meetings, capital, and duties of officers. It is not an announcement or summary but the substantive governance charter itself. This aligns with the Governance Information category (CGR).
2026-04-22 Chinese
2025年度独立董事履职报告（秦拯）
Governance Information Classification · 85% confidence The document is titled as a 2025 Independent Director Performance Report by an independent board member detailing governance activities, meeting attendance, committee oversight, and compliance with governance laws and company charter. It is not an earnings report, financing update, or announcement of a report publication, but a substantive governance document outlining board and committee practices. This fits the definition of Governance Information (CGR).
2026-04-22 Chinese
益丰药房关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 80% confidence The document is a corporate announcement titled “关于使用闲置募集资金进行现金管理的进展公告” (Progress Announcement on Using Idle Raised Funds for Cash Management). It details how the company’s board approved using idle proceeds from a convertible bond issuance for short‐term cash management, including amounts, products, yields, board resolutions, and risk controls. This is not a financial report (10‐K, IR), not a dividend or voting notice, and not management change information. It falls under updates on the use of financing proceeds and capital management activities, matching the Capital/Financing Update category (CAP).
2026-04-20 Chinese
益丰药房关于开立募集资金暂时补流专户并签署三方监管协议的公告
Capital/Financing Update Classification · 90% confidence The document is a corporate announcement about the establishment of special accounts and signing of a three‐party supervision agreement for temporarily supplementing liquidity with proceeds from a recently issued convertible bond. It focuses on the management and use of fundraising proceeds. This fits squarely under “Capital/Financing Update” (CAP).
2026-04-17 Chinese
益丰药房关于使用部分闲置募集资金暂时补充流动资金的公告
Capital/Financing Update Classification · 85% confidence The document is an official announcement by the board of 益丰大药房 regarding the temporary use of idle funds raised via a convertible bond issuance to supplement working capital. It details the original financing (可转换公司债券募集情况), uses of proceeds, board approval, regulatory compliance, and planned timeline for return of funds. This is not a full annual or interim report, nor a dividend or management change notice, but rather an update on the company’s financing proceeds and their deployment. This falls squarely under “Capital/Financing Update” (CAP).
2026-04-15 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见
Regulatory Filings Classification · 85% confidence The document is a sponsor’s verification opinion (“核查意见”) by CITIC Securities concerning the use of idle proceeds from a previously issued convertible bond offering. It does not represent an annual or interim financial report, earnings release, management discussion, or a presentation, nor is it announcing a dividend, share issue, M&A, or insider transaction. Rather, it is a stand-alone regulatory filing providing formal opinions per Shanghai Stock Exchange rules on the temporary use of raised funds. Therefore, it best fits the fallback category “Regulatory Filings” (RNS).
2026-04-15 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.